Drug Design, Development and Therapy, 1177-8881

Tidskrift

Fler filtreringsmöjligheter
  1. 2019
  2. The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies

    Wang, T., Yu, J., Liu, M., Chen, Y., Zhu, C., Lu, L., Wang, M., Min, L., Liu, X., Zhang, X., Gubat, J. A. & Chen, Y., 2019, I : Drug Design, Development and Therapy. 13, s. 539-553 15 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2016
  4. Two phase ii randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma

    Kuna, P., Leif Bjermer & Tornling, G., 2016 aug 31, I : Drug Design, Development and Therapy. 10, s. 2759-2770 12 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2015
  6. Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA).

    Leif Bjermer, Kuna, P., Jorup, C., Bengtsson, T. & Rosenborg, J., 2015, I : Drug Design, Development and Therapy. 9, s. 753-762

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2013
  8. Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer

    Semenas, J., Dizeyi, N. & Persson, J. L., 2013, I : Drug Design, Development and Therapy. 7, s. 875-881

    Forskningsoutput: TidskriftsbidragÖversiktsartikel